Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts

J. S. Cho, Y. M. Moon, Il Ho Park, J. Y. Um, J. H. Moon, S. J. Park, S. H. Lee, H. J. Kang, Heung Man Lee

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Background Nasal polyposis is a multi-factorial disease associated with chronic inflammatory condition of the paranasal sinuses. Myofibroblast differentiation and extracellular matrix (ECM) accumulation are involved in the pathogenesis of nasal polyposis. Objective The aim of this study was to study the effect of trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, on transforming growth factor (TGF)-b1-induced myofibroblast differentiation and ECM accumulation in nasal polyp-derived fibroblasts (NPDFs). Methods Nasal polyp-derived fibroblasts were isolated from nasal polyps of patients who have chronic rhinosinusitis with nasal polyp. TSA was treated in TGF-b1-induced NPDFs. Expression levels of HDAC2, a-smooth muscle actin (SMA), TGF-b1, collagen type I, acetylated Histone H3, acetylated Histone H4, phosphorylated Smad2/3 and Smad7 were determined by RT-PCR, western blot and/or immunofluorescent staining. The total collagen amount production was analysed by Sircol soluble collagen assay and contractile activity was measured by collagen gel contraction assay. HDAC2 inhibition by TSA or HDAC2 silencing was established by RT-PCR and western blot. The epigenetic effect on a-SMA gene inactivation was examined by chromatin immunoprecipitation assay. Proliferation was determined by Ki67-positive cell staining and cytotoxicity was assessed by 3-(4,5- dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Results The expression levels of HDAC2, a-SMA and TGF-b1 were increased in nasal polyp tissues compared to normal inferior turbinate tissues. TSA and HDAC2 silencing inhibited expression levels a-SMA, collagen and HDAC2. TSA induced hyperacetylation of histone and suppressed opening of a-SMA gene promoter in TGF-b1-induced NPDFs. TSA inhibited TGF-b1-induced Smad 2/3 and rescued TGF-b1-suppressed Smad7 signalling pathway. Finally, TSA blocked proliferation in TGF-b1-induced NPDFs and has no cytotoxic effect in NPDFs. Conclusions and Clinical Relevance These results suggest that HDAC inhibition is associated with myofibroblast differentiation and extracelluar matrix accumulation in nasal polyposis. TSA may be useful as an inhibitor of nasal polyp growth, and thus has potential to be used as a novel treatment option for nasal polyposis.

Original languageEnglish
Pages (from-to)872-882
Number of pages11
JournalClinical and Experimental Allergy
Volume42
Issue number6
DOIs
Publication statusPublished - 2012 Jun 1

Fingerprint

trichostatin A
Nasal Polyps
Myofibroblasts
Epigenomics
Extracellular Matrix
Transforming Growth Factors
Fibroblasts
Smooth Muscle
Actins
Nose
Collagen
Histones
Western Blotting
Staining and Labeling
Turbinates
Polymerase Chain Reaction
Histone Deacetylase Inhibitors
Histone Deacetylases
Chromatin Immunoprecipitation
Paranasal Sinuses

Keywords

  • Extracellular matrix
  • Histone deacetylase
  • Myofibroblasts
  • Nasal polyp-derived fibroblasts
  • Nasal polyposis
  • TGF-β1
  • Trichostatin A

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. / Cho, J. S.; Moon, Y. M.; Park, Il Ho; Um, J. Y.; Moon, J. H.; Park, S. J.; Lee, S. H.; Kang, H. J.; Lee, Heung Man.

In: Clinical and Experimental Allergy, Vol. 42, No. 6, 01.06.2012, p. 872-882.

Research output: Contribution to journalArticle

Cho, J. S. ; Moon, Y. M. ; Park, Il Ho ; Um, J. Y. ; Moon, J. H. ; Park, S. J. ; Lee, S. H. ; Kang, H. J. ; Lee, Heung Man. / Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. In: Clinical and Experimental Allergy. 2012 ; Vol. 42, No. 6. pp. 872-882.
@article{ae45830f9a684914a6e6ab936fcd2625,
title = "Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts",
abstract = "Background Nasal polyposis is a multi-factorial disease associated with chronic inflammatory condition of the paranasal sinuses. Myofibroblast differentiation and extracellular matrix (ECM) accumulation are involved in the pathogenesis of nasal polyposis. Objective The aim of this study was to study the effect of trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, on transforming growth factor (TGF)-b1-induced myofibroblast differentiation and ECM accumulation in nasal polyp-derived fibroblasts (NPDFs). Methods Nasal polyp-derived fibroblasts were isolated from nasal polyps of patients who have chronic rhinosinusitis with nasal polyp. TSA was treated in TGF-b1-induced NPDFs. Expression levels of HDAC2, a-smooth muscle actin (SMA), TGF-b1, collagen type I, acetylated Histone H3, acetylated Histone H4, phosphorylated Smad2/3 and Smad7 were determined by RT-PCR, western blot and/or immunofluorescent staining. The total collagen amount production was analysed by Sircol soluble collagen assay and contractile activity was measured by collagen gel contraction assay. HDAC2 inhibition by TSA or HDAC2 silencing was established by RT-PCR and western blot. The epigenetic effect on a-SMA gene inactivation was examined by chromatin immunoprecipitation assay. Proliferation was determined by Ki67-positive cell staining and cytotoxicity was assessed by 3-(4,5- dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Results The expression levels of HDAC2, a-SMA and TGF-b1 were increased in nasal polyp tissues compared to normal inferior turbinate tissues. TSA and HDAC2 silencing inhibited expression levels a-SMA, collagen and HDAC2. TSA induced hyperacetylation of histone and suppressed opening of a-SMA gene promoter in TGF-b1-induced NPDFs. TSA inhibited TGF-b1-induced Smad 2/3 and rescued TGF-b1-suppressed Smad7 signalling pathway. Finally, TSA blocked proliferation in TGF-b1-induced NPDFs and has no cytotoxic effect in NPDFs. Conclusions and Clinical Relevance These results suggest that HDAC inhibition is associated with myofibroblast differentiation and extracelluar matrix accumulation in nasal polyposis. TSA may be useful as an inhibitor of nasal polyp growth, and thus has potential to be used as a novel treatment option for nasal polyposis.",
keywords = "Extracellular matrix, Histone deacetylase, Myofibroblasts, Nasal polyp-derived fibroblasts, Nasal polyposis, TGF-β1, Trichostatin A",
author = "Cho, {J. S.} and Moon, {Y. M.} and Park, {Il Ho} and Um, {J. Y.} and Moon, {J. H.} and Park, {S. J.} and Lee, {S. H.} and Kang, {H. J.} and Lee, {Heung Man}",
year = "2012",
month = "6",
day = "1",
doi = "10.1111/j.1365-2222.2011.03931.x",
language = "English",
volume = "42",
pages = "872--882",
journal = "Clinical and Experimental Allergy",
issn = "0954-7894",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts

AU - Cho, J. S.

AU - Moon, Y. M.

AU - Park, Il Ho

AU - Um, J. Y.

AU - Moon, J. H.

AU - Park, S. J.

AU - Lee, S. H.

AU - Kang, H. J.

AU - Lee, Heung Man

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Background Nasal polyposis is a multi-factorial disease associated with chronic inflammatory condition of the paranasal sinuses. Myofibroblast differentiation and extracellular matrix (ECM) accumulation are involved in the pathogenesis of nasal polyposis. Objective The aim of this study was to study the effect of trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, on transforming growth factor (TGF)-b1-induced myofibroblast differentiation and ECM accumulation in nasal polyp-derived fibroblasts (NPDFs). Methods Nasal polyp-derived fibroblasts were isolated from nasal polyps of patients who have chronic rhinosinusitis with nasal polyp. TSA was treated in TGF-b1-induced NPDFs. Expression levels of HDAC2, a-smooth muscle actin (SMA), TGF-b1, collagen type I, acetylated Histone H3, acetylated Histone H4, phosphorylated Smad2/3 and Smad7 were determined by RT-PCR, western blot and/or immunofluorescent staining. The total collagen amount production was analysed by Sircol soluble collagen assay and contractile activity was measured by collagen gel contraction assay. HDAC2 inhibition by TSA or HDAC2 silencing was established by RT-PCR and western blot. The epigenetic effect on a-SMA gene inactivation was examined by chromatin immunoprecipitation assay. Proliferation was determined by Ki67-positive cell staining and cytotoxicity was assessed by 3-(4,5- dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Results The expression levels of HDAC2, a-SMA and TGF-b1 were increased in nasal polyp tissues compared to normal inferior turbinate tissues. TSA and HDAC2 silencing inhibited expression levels a-SMA, collagen and HDAC2. TSA induced hyperacetylation of histone and suppressed opening of a-SMA gene promoter in TGF-b1-induced NPDFs. TSA inhibited TGF-b1-induced Smad 2/3 and rescued TGF-b1-suppressed Smad7 signalling pathway. Finally, TSA blocked proliferation in TGF-b1-induced NPDFs and has no cytotoxic effect in NPDFs. Conclusions and Clinical Relevance These results suggest that HDAC inhibition is associated with myofibroblast differentiation and extracelluar matrix accumulation in nasal polyposis. TSA may be useful as an inhibitor of nasal polyp growth, and thus has potential to be used as a novel treatment option for nasal polyposis.

AB - Background Nasal polyposis is a multi-factorial disease associated with chronic inflammatory condition of the paranasal sinuses. Myofibroblast differentiation and extracellular matrix (ECM) accumulation are involved in the pathogenesis of nasal polyposis. Objective The aim of this study was to study the effect of trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, on transforming growth factor (TGF)-b1-induced myofibroblast differentiation and ECM accumulation in nasal polyp-derived fibroblasts (NPDFs). Methods Nasal polyp-derived fibroblasts were isolated from nasal polyps of patients who have chronic rhinosinusitis with nasal polyp. TSA was treated in TGF-b1-induced NPDFs. Expression levels of HDAC2, a-smooth muscle actin (SMA), TGF-b1, collagen type I, acetylated Histone H3, acetylated Histone H4, phosphorylated Smad2/3 and Smad7 were determined by RT-PCR, western blot and/or immunofluorescent staining. The total collagen amount production was analysed by Sircol soluble collagen assay and contractile activity was measured by collagen gel contraction assay. HDAC2 inhibition by TSA or HDAC2 silencing was established by RT-PCR and western blot. The epigenetic effect on a-SMA gene inactivation was examined by chromatin immunoprecipitation assay. Proliferation was determined by Ki67-positive cell staining and cytotoxicity was assessed by 3-(4,5- dimethylthiazol-2yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay. Results The expression levels of HDAC2, a-SMA and TGF-b1 were increased in nasal polyp tissues compared to normal inferior turbinate tissues. TSA and HDAC2 silencing inhibited expression levels a-SMA, collagen and HDAC2. TSA induced hyperacetylation of histone and suppressed opening of a-SMA gene promoter in TGF-b1-induced NPDFs. TSA inhibited TGF-b1-induced Smad 2/3 and rescued TGF-b1-suppressed Smad7 signalling pathway. Finally, TSA blocked proliferation in TGF-b1-induced NPDFs and has no cytotoxic effect in NPDFs. Conclusions and Clinical Relevance These results suggest that HDAC inhibition is associated with myofibroblast differentiation and extracelluar matrix accumulation in nasal polyposis. TSA may be useful as an inhibitor of nasal polyp growth, and thus has potential to be used as a novel treatment option for nasal polyposis.

KW - Extracellular matrix

KW - Histone deacetylase

KW - Myofibroblasts

KW - Nasal polyp-derived fibroblasts

KW - Nasal polyposis

KW - TGF-β1

KW - Trichostatin A

UR - http://www.scopus.com/inward/record.url?scp=84863817342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863817342&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2222.2011.03931.x

DO - 10.1111/j.1365-2222.2011.03931.x

M3 - Article

VL - 42

SP - 872

EP - 882

JO - Clinical and Experimental Allergy

JF - Clinical and Experimental Allergy

SN - 0954-7894

IS - 6

ER -